We are a team of scientists and entrepreneurs with extensive experience in the biotechnology and pharmaceutical industries, dedicated to improving the lives of people with chronic wounds worldwide.

Chronic wounds are a public health issue affecting 120 million people who deal with chronic pain, infections, amputations, depression, insomnia, and other issues, while wound management costs the public health system billions of dollars annually. Our gel has earned recognition from institutions such as Singularity University, Massachusetts Institute of Technology (MIT), Stanford University, the Barceló Institute, and the IAE Business School, and we have received first prizes at numerous national and international scientific conferences. As a result, we have been published in books and papers in the United States, Japan, and Spain.